27-hydroxycholesterol has been researched along with Hepatitis C, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adami, M; Cavalli, R; Civra, A; Costantino, M; Lembo, D; Poli, G; Volante, M | 1 |
1 other study(ies) available for 27-hydroxycholesterol and Hepatitis C, Chronic
| Article | Year |
|---|---|
27-Hydroxycholesterol inhibits rhinovirus replication in vitro and on human nasal and bronchial histocultures without selecting viral resistant variants.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hydroxycholesterols; Rhinovirus | 2022 |